PE20061005A1 - DERIVATIVES OF A 5-MEMBER STRAIGHT RING DIARY REPLACED - Google Patents
DERIVATIVES OF A 5-MEMBER STRAIGHT RING DIARY REPLACEDInfo
- Publication number
- PE20061005A1 PE20061005A1 PE2005001069A PE2005001069A PE20061005A1 PE 20061005 A1 PE20061005 A1 PE 20061005A1 PE 2005001069 A PE2005001069 A PE 2005001069A PE 2005001069 A PE2005001069 A PE 2005001069A PE 20061005 A1 PE20061005 A1 PE 20061005A1
- Authority
- PE
- Peru
- Prior art keywords
- methyl
- diary
- derivatives
- replaced
- fluoropyridin
- Prior art date
Links
- -1 QUINOLINYL Chemical group 0.000 abstract 6
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000002193 Pain Diseases 0.000 abstract 2
- 208000014644 Brain disease Diseases 0.000 abstract 1
- 208000000094 Chronic Pain Diseases 0.000 abstract 1
- 206010010904 Convulsion Diseases 0.000 abstract 1
- 206010065390 Inflammatory pain Diseases 0.000 abstract 1
- 208000028017 Psychotic disease Diseases 0.000 abstract 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 abstract 1
- 208000005298 acute pain Diseases 0.000 abstract 1
- 230000036461 convulsion Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical class 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
SE REFIERE A UN COMPUESTO DE FORMULA I, DONDE R1 ES QUINOLINILO, INDANILO, ISOINDOLINILO, 3,4-DIHIDROQUINAZOLINILO, ENTRE OTROS; R2 ES H, ALQUILO INFERIOR; R3 ES FENILO O PIRIDILO SUSTITUIDO O NO POR 1-3 DE HALOGENO. SON COMPUESTOS PREFERIDOS: 1-(2-FLUOROPIRIDIN-3-IL)-5-METIL-4-(1-OXOINDENO-2-ESPIRO-1'-CICLOPROPIL-5-IL)-1H-[1,2,3]-TRIAZOL; 4-(2-ISOPROPIL-1-OXO-ISOINDOLINA-5-IL)-1-(2-FLUOROPIRIDIN-3-IL)-5-METIL-1H-[1,2,3]-TRIAZOL; 1-(4-FLUOROFENIL)-5-METIL-4-(2-(2-HIDROXI-2-METIL-PROPIL)-QUINOLIN-6-IL)-1H-[1,2,3]-TRIAZOL; ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. DICHOS COMPUESTOS SON INHIBIDORES DE mGLUR1, UTILES EN EL TRATAMIENTO DE CONVULSION, DOLOR AGUDO, DOLOR INFLAMATORIO, DOLOR CRONICO, TRASTORNOS CEREBRALES, TRASTORNOS PSICOTICOS, ENTRE OTROSREFERS TO A COMPOUND OF FORMULA I, WHERE R1 IS QUINOLINYL, INDANYL, ISOINDOLINYL, 3,4-DIHYDROQUINAZOLINYL, AMONG OTHERS; R2 IS H, LOWER ALKYL; R3 IS PHENYL OR PYRIDYL, SUBSTITUTED OR NOT BY 1-3 OF HALOGEN. PREFERRED COMPOUNDS ARE: 1- (2-FLUOROPYRIDIN-3-IL) -5-METHYL-4- (1-OXOINDENE-2-SPYRO-1'-CYCLOPROPYL-5-IL) -1H- [1,2,3] -TRIAZOL; 4- (2-ISOPROPYL-1-OXO-ISOINDOLINE-5-IL) -1- (2-FLUOROPYRIDIN-3-IL) -5-METHYL-1H- [1,2,3] -TRIAZOLE; 1- (4-FLUOROPHENYL) -5-METHYL-4- (2- (2-HYDROXY-2-METHYL-PROPYL) -QUINOLIN-6-IL) -1H- [1,2,3] -TRIAZOLE; AMONG OTHERS. IT ALSO REFERS TO A PHARMACEUTICAL COMPOSITION. SUCH COMPOUNDS ARE INHIBITORS OF mGLUR1, USEFUL IN THE TREATMENT OF CONVULSION, ACUTE PAIN, INFLAMMATORY PAIN, CHRONIC PAIN, BRAIN DISORDERS, PSYCHOTIC DISORDERS, AMONG OTHERS
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PE2005001069A PE20061005A1 (en) | 2005-09-15 | 2005-09-15 | DERIVATIVES OF A 5-MEMBER STRAIGHT RING DIARY REPLACED |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PE2005001069A PE20061005A1 (en) | 2005-09-15 | 2005-09-15 | DERIVATIVES OF A 5-MEMBER STRAIGHT RING DIARY REPLACED |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061005A1 true PE20061005A1 (en) | 2006-10-03 |
Family
ID=43499729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2005001069A PE20061005A1 (en) | 2005-09-15 | 2005-09-15 | DERIVATIVES OF A 5-MEMBER STRAIGHT RING DIARY REPLACED |
Country Status (1)
| Country | Link |
|---|---|
| PE (1) | PE20061005A1 (en) |
-
2005
- 2005-09-15 PE PE2005001069A patent/PE20061005A1/en not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2437882C2 (en) | Imidazolidinone derivatives | |
| PE20121510A1 (en) | ISOQUINOLINONES AND SUBSTITUTE QUINAZOLINONES | |
| PE20110433A1 (en) | ANTAGONISTS OF THE DISUSTITUTED PHTHALAZINE HEDGEHOG PATHWAY | |
| PE20080925A1 (en) | PYRROLO [2,3-b] PYRIDINE DERIVATIVES AS KINASE INHIBITORS, IN PARTICULAR IKK2 INHIBITORS (OR IKK BETA) | |
| MXPA05010816A (en) | 4- (4-(heterocyclylalkoxy} phenyl)-1 -(heterocyclyl- carbonyl) piperidine derivatives and related compounds as histamine h3 antagonists for the treatment of neurological diseases such as alzheimer. | |
| PE20061436A1 (en) | DERIVATIVES OF AMIDE SUBSTITUTED AS PROTEIN KINASE INHIBITORS | |
| PE20080951A1 (en) | DERIVATIVES OF 2-OXO-ETHYL-AMINO-PROPIONAMIDE-PYRROLIDIN-2-IL-SUBSTITUTED AS INHIBITORS OF THE BINDING OF THE PROTEIN Smac TO THE INHIBITOR OF THE PROTEIN OF APOPTOSIS | |
| ATE496043T1 (en) | 3-HETEROARYL (AMINO OR AMIDO)-1- (BIPHENYL OR PHENYLTHIAZOLYL) CARBONYLPIPERDINE DERIVATIVES AS OREXIN RECEPTOR INHIBITORS | |
| PE20090984A1 (en) | PEPTIDE DESFORMYLASE INHIBITORS | |
| PE20081845A1 (en) | NEW AMINOPYRIMIDINE DERIVATIVES AS PLK1 INHIBITORS | |
| TR200102789T2 (en) | 1-Arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of Cns disorders | |
| PE20131377A1 (en) | TRIAZINE-OXADIAZOLES | |
| TW200710086A (en) | Diaryl-substituted hetero 5-membered ring derivatives | |
| AR062965A1 (en) | MODULATING COMPOUNDS OF MGLUR5 GLUTAMATOMETABOTROPIC RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THERAPEUTIC USES IN ACUTE AND CHRONIC GASTROINTESTINAL, NEUROLOGICAL AND PSYCHIATRIC DISORDERS | |
| PE20050681A1 (en) | PYRID [2,3-d] PYRIMIDINE-2,4-DIAMINES AS INHIBITORS OF PDE 2 | |
| RU2008120850A (en) | COMPOUNDS AND COMPOSITIONS AS PROTEINKINASE INHIBITORS | |
| PE20091090A1 (en) | PIPERIDINE DERIVATIVES AS AGONISTS OF MUSCARINAL RECEPTORS | |
| MXPA05007115A (en) | Novel cb 1 receptor inverse agonists. | |
| PE20060937A1 (en) | SULFONYLBENZIMIDAZOLE DERIVATIVES AS CANNABINOID RECEPTOR 2 (CB2) AGONISTS | |
| PE20081665A1 (en) | RAPID DISSOCIATION DOPAMINE 2 RECEPTOR ANTAGONISTS | |
| PE20060625A1 (en) | BENZAZEPINE DERIVATIVES AS ANTAGONISTS AND / OR AGONISTS OF THE HISTAMINE H3 RECEPTOR | |
| PE20070795A1 (en) | PIRAZOLE-UREA-HETEROCICLIC COMPOUNDS AS KINASE INHIBITORS | |
| EA200600829A1 (en) | NEW CRYSTAL FORMS {2- [1- (3,5-BISTRIFTORMETHYLBENZYL) -5-Pyridine-4-IL-1H- [1,2,3] TRIAZOL-4-IL] -pyridine-3-IL} - (2 -CHLOROPHENYL) METHANON | |
| PE20050950A1 (en) | TRIAZOLE DERIVATIVES SUBSTITUTED AS OXYTOCIN ANTAGONISTS | |
| RU2372348C2 (en) | Indolylmaleimide derivatives as protein kinase c (pkc) inhibitors |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |